Affiliation:
1. Laboratory of Molecular Pharmacogenomics, Department of Pharmaceutical Sciences Kindai University Osaka Japan
2. Laboratory of Hygienic Science, Department of Pharmacy, School of Pharmacy Hyogo Medical University Kobe Japan
3. Laboratory of Pathological Biochemistry Kyoto Pharmaceutical University Kyoto Japan
Abstract
AbstractCalcineurin (CN) is a conserved Ca2+/calmodulin‐dependent phosphoprotein phosphatase that plays a key role in Ca2+ signaling. Regulator of calcineurin 1 (RCAN1), also known as Down syndrome critical region gene 1 (DSCR1), interacts with calcineurin and inhibits calcineurin‐dependent signaling in various organisms. Ppb1, the fission yeast calcineurin regulates Cl−‐homeostasis, and Ppb1 deletion induces MgCl2 hypersensitivity. Here, we characterize the conserved and novel roles of the fission yeast RCAN1 homolog rcn1+. Consistent with its role as an endogenous calcineurin inhibitor, Rcn1 overproduction reproduced the calcineurin‐null phenotypes, including MgCl2 hypersensitivity and inhibition of calcineurin signaling upon extracellular Ca2+ stimuli as evaluated by the nuclear translocation and transcriptional activation of the calcineurin substrate Prz1. Notably, overexpression of rcn1+ causes hypersensitivity to arsenite, whereas calcineurin deletion induces arsenite tolerance, showing a phenotypic discrepancy between Rcn1 overexpression and calcineurin deletion. Importantly, although Rcn1 deletion induces modest sensitivities to arsenite and MgCl2 in wild‐type cells, the arsenite tolerance, but not MgCl2 sensitivity, associated with Ppb1 deletion was markedly suppressed by Rcn1 deletion. Collectively, our findings reveal a previously unrecognized functional collaboration between Rcn1 and calcineurin, wherein Rcn1 not only negatively regulates calcineurin in the Cl− homeostasis, but also Rcn1 mediates calcineurin signaling to modulate arsenite cytotoxicity.
Funder
Japan Society for the Promotion of Science
Ministry of Education, Culture, Sports, Science and Technology